Restoration of Hypoglycemia Awareness With Metoclopramide
Status:
Recruiting
Trial end date:
2025-03-31
Target enrollment:
Participant gender:
Summary
Metoclopramide is a drug approved by the FDA for gastroesophageal reflux and to relieve
symptoms in adults with acute and recurrent diabetic gastroparesis. The objective of this
study is to determine whether metoclopramide can improve hypoglycemia awareness and decrease
the incidence of hypoglycemia in type 1 diabetes patients with hypoglycemia unawareness.
Phase:
Phase 2
Details
Lead Sponsor:
Simon Fisher
Collaborator:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)